AzTrials
AzTrials

Sleep Apnea, ObstructiveQOMASNCT06386341

QoL in OSA patiënts Treated With MMA Surgery.

An observational study of Sleep Apnea, Obstructive and Quality of Life, run by Diakonessenhuis, Utrecht at 1 site in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this observational study is to evaluate the impact of maxillomandibular advancement surgery on the quality of life in patients treated with obstructive sleep apnea. The main question it aims to answer is: Does MMA surgery in OSA patiënts improve their quality of life? Patients will answer online surverys… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Sleep Apnea, Obstructive, Quality of Life
What is being tested?
Maxillomandibular Advancement Surgery
Type of treatment
Surgery or procedure
How many people
80 participants
Where
1 siteNetherlands
Study dates
2 Aug 2023to 2 Aug 2026
How long will I take part?
3 Years
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients undergoing maxillomandibular advancement surgery for OSA (intervention group) or other reasons (control group).

Who may be able to join

  • 18 years and older.
  • Ability to speak, read and write Dutch.
  • Ability to follow up.
  • Ability to use a computer with internet connection and windows-software for uploading data
  • and online questionnaires.
  • Diagnosis with OSA. (only for the intervention group)
Show all 9Show fewer
  • Expected to maintain current lifestyle (sports, medicine, diet etc.).
  • Qualifies for MMA surgery
  • Patients who provide informed consent

Who cannot join

  • Patients who do not qualify for MMA surgery
  • Medication used/ related to sleeping disorders.
  • Night or shifting work.
  • Severe chronic heart failure.
  • Medical history of known causes of tiredness by day or severe sleep disruption (insomnia,
  • PLMS, Narcolepsy).
Show all 18Show fewer
  • Seizure disorder.
  • Known medical history of mental retardation, memory disorders or psychiatric disorders.
  • Patients with old type of pacemakers (It is possible that old types of peacemakers are not
  • Compatible with the electromagnetic radiation of the electronics of the SPT).
  • Shoulder, neck and back complaints.
  • Reversible morphological upper airway abnormalities (e.g. enlarged tonsils).
  • Inability to provide informed consent.
  • Simultaneous use of other treatment modalities to treat OSA.
  • Previous treatment for OSA with MRA or SPT
  • Pregnancy.
  • patients under the age of 18
  • Patients with mild or no OSA at all

Trial locations and contacts

1 site in 1 country.

Netherlands1 site, 1 recruiting
  • Diakonessenhuis

    Utrecht, 3582KE

    Susanne Leij, 088-250 6172, sleij@diakhuis.nl

    Maurits de Ruiter, MD, DDS, PHD

    Recruiting

Other trials in Netherlands

About this study

Official title: Quality of Life in Obstructive Sleep Apnea patiënts Treated With Maxillomandibular Advancement Surgery.

The aim of this observational study is to evaluate the impact of maxillomandibular advancement surgery on the quality of life in patients treated with obstructive sleep apnea.

The main question it aims to answer is:

Does MMA surgery in OSA patiënts improve their quality of life?

Patients will answer online surverys about their QoL and there will be data collected like length, weight and blood pressure.

Read the detailed description

The aim of this study is to evaluate the impact of MMA surgery on the quality of life of patients with obstructive sleep apnea.

It was hypnotized that MMA does not result in a significant improvement in the quality of life in patients with OSA.

The main objective is the SF-36 questionnaire The secondary objectives are the; OHIP-14, ESS, FOSQ, EQ-5D-3L and OQLQ

Design: observational study

Study population: 80 Patients who qualify for MMA above the age of 18

The patients will be recruited at the departments of Oral and Maxillofacial surgery. Individuals who match the next inclusion and exclusion criteria will be the population base of this study.There will also be a control group.These patients will have the same inclusion and exclusion criteria next to the diagnosis with OSA. The control group will be a group of patients without OSA.

Inclusion criteria for this research are:

  • 18 years and older.
  • Ability to speak, read and write Dutch.
  • Ability to follow up.
  • Ability to use a mobile device with internet connection for the online questionnaires.
  • Diagnosis with OSA. (only for the intervention group)
  • Expected to maintain current lifestyle (sports, medicine, diet etc.).
  • Qualifies for MMA surgery
  • Patients who provide informed consent

Exclusion criteria for this research:

  • Patients who do not qualify for MMA surgery
  • Medication used/ related to sleeping disorders.
  • Night or shifting work.
  • Severe chronic heart failure.
  • Medical history of known causes of tiredness by day or severe sleep disruption (insomnia,
  • PLMS, Narcolepsy).
  • Seizure disorder.
  • Known medical history of mental retardation, memory disorders or psychiatric disorders.
  • Patients with old type of pacemakers (It is possible that old types of peacemakers are not
  • Compatible with the electromagnetic radiation of the electronics of the SPT).
  • Shoulder, neck and back complaints.
  • Reversible morphological upper airway abnormalities (e.g. enlarged tonsils).
  • Inability to provide informed consent.
  • Simultaneous use of other treatment modalities to treat OSA.
  • Previous treatment for OSA with MRA or SPT
  • Pregnancy.
  • patients under the age of 18
  • Patients with mild or no OSA at all (if patient meets this criteria they will be part of the control group)

In total there will be 80 patients included.

There will be no intervention done for the purpose of this study. But the intervention that will be observed is how the MMA effects the Quality of Life of the patients who underwent this surgery. We are going to prospective observe them and follow them up through their procedure.

The responsible researcher will introduce the research to the patients. When patients meet the inclusion criteria they will be asked to participate in the research. The decision regarding participation in the study, which is made by the patient, is entirely voluntary. Patients are given two weeks time to consider joining the study population. Refusal of participation will have no consequences for further treatment of the patient. They will be asked to sign informed consent.

Being tested
Maxillomandibular Advancement Surgery
Keywords
Sleep Apnea, Obstructive, Quality of Life, Surgery, Oral
Medical subject headings
Sleep Apnea, Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Maxillomandibular Advancement SurgeryProcedure or surgery

    Surgery where the upper and lower jaw are repositioned.

Study groups in NCT06386341
Study groupRoleWhat they receive
Intervention groupPatiënts who underwent MMA surgery for OSA.
Receives: Procedure: Maxillomandibular Advancement Surgery
Control groupPatiënts who underwent MMA surgery for other reasons than OSA.
Receives: Procedure: Maxillomandibular Advancement Surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. SF-36

    Survey

    Measured: 5 minutes

Secondary outcomes (5)
  1. OHIP-14

    Survey

    Measured: 5 minutes

  2. ESS

    Survey

    Measured: 5 minutes

  3. FOSQ

    Survey

    Measured: 5 minutes

  4. EQ-5D-3L

    Survey

    Measured: 5 minutes

  5. OQLQ

    Survey

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2024
  2. Study start2 Aug 2023
  3. Primary completion2 Aug 2026 (estimated)
  4. Study completion2 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (estimated)
Target duration
3 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT06386341
Sponsor's protocol ID
W23.154
Acronym
QOMAS
Status last verified
Aug 2023
First submitted
23 Apr 2024
Last updated
26 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Sleep Apnea, Obstructive and Quality of Life, run by Diakonessenhuis, Utrecht at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

SF-36 (time frame: 5 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in